RBM17 and acute myeloid leukemia: Using isoform-specific RT-PCR in AML cell lines and primary AML samples, we then validated that RBM17 knockdown promoted inclusion of the poison exons/introns for each of the abovementioned targets (Fig. 5b–d, Supplementary Fig. 4a, b).